Theme: Neuro Oncology and Treating Brain Tumour challenges with COVID-19 pandemic

Neuro Oncology 2020

Renowned Speakers

Neuro Oncology 2020

Dear Colleagues,

Conference Series extends its welcome to the conference 6th International Conference on Neuro-Oncology and Brain Tumor (Neuro Oncology 2020) webinar during June 22-23, 2020 with a theme “ Neuro Oncology and Treating Brain Tumour challenges with COVID-19 pandemic”. Conference Series through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. Conference Series llc LTD Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members. Neuro Oncology 2020, Conference will focus on educational research directed toward its impact on clinical outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations. Neuro-Oncology 2020 is a perfect platform to find out how Neuro-Oncology research innovations helpful to the Medical, Health and human society. Conference will mainly focus on the trending topics during presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of Neuro-Oncology and medical sectors.

The Conference Neuro Oncology 2020

We are happy to welcome you to the official website of 6th International Conference on Neuro-Oncology and Brain Tumor (Neuro Oncology 2020) webinar during June 22-23, 2020 Brisbane, Australia with the theme of " Neuro Oncology and Treating Brain Tumour challenges with COVID-19 pandemic " which covers wide range of critically important sessions. It’s a platform to bring all the neurooncologists and brain tumor specialists together to share their experiences it’s the amalgam of scientific research as well as innovative ideas.

Overview of Neuro-oncology and Brain tumour:

An important area of clinical Neuro-Oncology and Brain Tumour that is increasingly relevant as survivorship increases and as patients experience potential morbidities associated with new therapies. Neuro-Oncology is the study of Brain and Spinal cord neoplasms, many of which are   (at least eventually) very dangerous and life-threatening (Astrocytoma, Glioma, Glioblastoma multiforme, Ependymoma, Pontine Glioma, and Brain stem tumors are among the many examples of these). Among the Malignant Brain cancers, Gliomas of the brainstem and pons, Glioblastoma multiform, and high-grade (highly anaplastic) Astrocytoma are among the worst.

Geographically market is segmented into Europe, North America, Latin America, Asia pacific, and Middle East and Africa. According to market study, Market Value for Neuro Oncology (i.e. on Brain Cancer and CNS Tumors) will be more than double to $ 623 Million by 2020. A major part of research is going on the top Universities on across the globe. Many companies are associated with various diagnostic instruments and other therapeutics. Besides this various societies and research labs are also associated in this research field.

Who Should Attend?

  • Directors
  • Head of Department
  • Professors
  • Industrial Researchers
  • Academic Scientist
  • Neuro-oncologist
  • Brain cancer specialists
  • Radiation Oncologists
  • Oncologists
  • Cancer Pharmaceutical Companies
  • Cancer Institutes
  • Neuropediatricians
  • Neurosurgeons
  • Radiation oncologists
  • Neuro-Pathologists
  • Rehabilitation Specialists
  • Research and Development Department.
  • Laboratory Professionals
  • Ph.D. Students
  • Upcoming researchers
  • Nursing scholars
  • Researchers
  • Business Delegates
  • Hospital presidents/CEOs/COOs/VPs/trustees
  • Hospital c-suite executives (operations, development, finance)
  • Healthcare consultants, vendors, and suppliers
  • Cancer program marketing and public relations professionals
  • Cancer Researchers and Students from academia in the research of Neuro-oncology, Neurooncology Associations, Brain cancer societies, cancer communities, Medical Colleges

Target Audience:

Academia: 65%

Industry: 25%

Others: 10%

Target Audience for the conference are Physicians and Allied Health Professionals in the field of:

  •         Adult Medical Oncology
  •         Pediatric Oncology and Hematology
  •         Neuro-Oncology
  •         Neurosurgery
  •         Radiation Oncology
  •         Neuropathology in cancer

Why to attend?

6th International Conference on Neuro-Oncology and Brain Tumor tends to bring together worldwide distinguished academics in the field of Neuro-oncologist, Oncologist, Radiation Oncologist, Medical Oncologists, pharmacologists, Brain cancer specialists, Pediatric Neuro Oncologists, Neuroscience  Brain researchers, Public Health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art Research and Technologies and to bring discoveries of cancer to Patients. Attending International conference is for the Professional Development and to understand the current state of research and the challenges to future discovery.
The aim of the Conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

For more details please visit:

 Who should sponsor/exhibit:       

  • Hospitals, Health care
  • Educational Institutes
  • Cancer research Centres, assocations, societies, industries,Communities,Cancer pharma industries.
  • Charitable Foundations focused on funding research, advocating for and supporting the needs

Benefits of attending:

  • Networking Opportunities, Grow Your Professional Network
  • Build Your Knowledge Base
  • Expand Your Resources
  • Meet Experts & Influencers Face to Face
  • Learning in a New Space
  • Break Out of Your Comfort Zone
  • New Tips & Tactics
  • Greater Focus
  • Top Industries Representation
  • Abstracts will be published in the conference souvenir and respective International journals
  • Each Abstract will receive unique (DOI) Number provided by Cross Ref
  • Website visibility to more than 35K visitors in less than 6 months
  •  Laudable talks by the top-notch of the Global Scientific Community
  • The Serendipity of the Random Workshop
  • Will be felicitated with International Organizing Committee Member (IOCM)
  • Remarkable Awards and Global Recognition to meritorious Researchers

It is our pleasure to invite you for the conference “6th International Conference on Neuro-Oncology and Brain Tumor” going to be held during June 22-23, 2020 at Brisbane, Australia. The main theme of our conference is “Neuro Oncology and Treating Brain Tumour challenges with COVID-19 pandemic “which covers wide range of critically important sessions.

Around 1 billion people, nearly one in six of the world’s population, suffer from Brain disorders like Neuro oncology, Brain tumor, Metastatic cancer, Glioblastoma multiforme, Meningioma, Astrocytoma, Brain injuries and pediatric neuro oncology.

The World Health Organization estimated that Brain disorders affect up to one Billion people Worldwide. In fact, Brain diseases make up 11% of the World’s disease burden, not including mental health and addiction disorders.

Track 1:  Neuro-Oncology

Neuro-oncology is defined the study of brain and spinal cord neoplasms, many of which are (at least eventually) very dangerous and life-threatening (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumors are among the many examples of these). Among the malignant brain cancers, brainstem glioma and pons, glioblastoma multiforme, and high-grade (highly anaplastic) astrocytoma are among the worst. In these cases, untreated survival usually amounts to only a few months, and survival with current radiation and chemotherapy treatments may extend that time from around a year to a year , possibly two or more, depending on the patient's condition, immune function, treatments are used, and the specific type of malignant brain neoplasm.

Global Central Nervous System Drugs market to grow at a CAGR of -3.2% over the period 2011-2019. The global central nervous system (CNS) therapeutics peddle has been forecast to reach US$135 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.

Track 2:  Brain Tumor

A brain tumor is occurs when abnormal cells form within the brain. There are two main types of tumors: cancerous (malignant) tumors and benign (non-cancerous) tumors. Malignant tumors can be divided into primary tumors, which start within the brain, and secondary tumors, which have spread from elsewhere, known as brain metastasis tumors. All types of brain tumors may produce some symptoms that vary depending on the part of the brain involved. These symptoms may include headaches, seizures, muscle weakness, problems with vision, vomiting and mental changes. The headache is classically worse in the morning and goes away with vomiting. Other symptoms may include difficulty walking, dizziness, speaking or with sensations. Any brain tumor is inherently serious and life-threatening because of its invasive and infiltration character in the limited space of the Intracranial Cavity.

Track 3:  Metastatic Cancer

Metastatic Cancer can spread from where it obtained to another part of the body (such as the breast or lungs). Metastatic tumors are considered cancer and are malignant. The cancer in another part of the body is called as metastatic or secondary cancer. For an example, when colon cancer spreads to the liver, the cancer cells in the liver are colon cancer cells. It is metastatic colon cancer, not liver cancer.

Metastatic cancer is also called:

  • metastatic tumour, tumours or disease
  • metastasis (one cancerous tumour)
  • metastases (more than one cancerous tumour)
  • Spinal Cord Metastasis
  • Brain Metastasis
  • Leptomeningeal Metastasis

Track 4:  Meningioma

Meningioma is referred as to slow growing Brain tumors, but their origin is not from the Brain tissue. Meningitis are often benign tumors arising from the Arachnoidal cells of Meninges of the brain and spinal cord. Meningiomas usually grow inward slowly, causing pressure on the Brain or Spinal cord. They interfere with the normal functions of the Brain after reaching large size. They represent about one-third of all Primary Brain Tumors and occur most frequently in middle-aged females.

Track 5:  Neoplasms

Neoplasm is defined an abnormal growth of tissue, which forms a mass that commonly referred to as a Tumor. Neoplasm can be caused by an Abnormal Proliferation of Tissues, that which can be caused by Genetic mutations. Not all types of Neoplasms causes a tumorous overgrowth of tissue. Malignant Neoplasms are derived from epithelial cells called Carcinomas. The growth of a neoplasm is an uncoordinated with that of the normal surrounding tissue, and it persists growing abnormally, even if the original trigger is removed.

Track 6:  Pediatric Neuro oncology

Paediatric Neuro oncology is the term used to encompass all malignant conditions among children with cancer, including blood conditions such as leukaemia, paediatric oncologists and paediatric haematologists, work within a national framework of cancer to ensure they provide the most effective care. The major range of cancers in children include leukemia, lymphomas brain tumors. Most of the cancers affecting children differ from those affecting adults. They occurs different parts of the body; appear differently under the microscope and respond differently for treatment. Treatment is frequently complex and intensive but cure rates among children are much higher than for most adult brain cancers/neuro oncology.

  • Brain Tumors
  • Diagnosis & Treatment of neuro oncology
  • Risk Factors Associated
  • Paediatric neuro Oncology Nursing
  • Medications & Care for Neuro Oncology
  • Blood Malignancies
  • Leukemia
  • Lymphoma

Track 7:  Gangliocytomas

Gangliocytoma is rare indolent CNS tumours which are made up of mature neurons arising anywhere within the Neuroaxis. They differ from gangliogliomas as they lacks of neoplastic glial cells. Treatment involves surgical removal of the tumour. These are Neuroepithelial Tumors which line the ventricles of the brain and produces Cerebrospinal fluid.

Track 8:  Choroid Plexus Tumor

Choroid Plexus Tumor arises from Brain tissue that invades nearby tissue and spread widely through the cerebrospinal fluid. Other brain tumors like choroid plexus tumors are also “graded.” Choroid Plexus Neoplasms are rare, Primary Central Nervous System (CNS) tumors derived from Choroid Plexus Epithelium that are seen predominantly in children.

Track 9:  Brainstem Glioma

A Brainstem glioma is an aggressive and dangerous Cancerous Glioma Tumor in the brainstem which starts in the Brain or Spinal cord tissue and typically spread throughout the Nervous System of brain. It is more diagnosed in children and young adults under the age of nineteen. Symptoms  of Brainstem glioma can develop slowly and may go unnoticed since months. A sudden onset symptoms are  tends to occur with more rapidly growing high-grade tumors. In other cases, the symptoms may arise immediately. Unlike most Brain tumors, Brainstem Glioma is not often treated with Neurosurgery due to vital complications Parts of the Brain. Without treatment, the life expectancy is typically a few months from the time of diagnosis.

Track 10: Neuropsychology in Cancer

The Psychosocial and Neurocognitive functioning of several cancer patients and survivors deleteriously affected by various treatments of Malignant tumors such as Chemotherapy, Radiotherapy and Hormonal therapy. Oncology researchers and Clinicians are increasingly Cognizant of the negative effects of Cancer and its treatments on the Brain and its mental processes and Cognitive outcomes.

Neuropsychology in Cancer features the current findings on the Neuropsychological effects of the Cancers and their treatments along with the most promising Neuropsychological and behavioural health interventions available to mitigate these deficits.

Track 11:  Angiogenesis in neuro Oncology

Angiogenesis theatrically a critical role in the maturation and spread of cancer, it also plays a major role in the transition of tumor cells from a benign state to a malignant (cancerous), leading to the use of angiogenesis evasion in the treatment of cancer.

Track 12:   Novel Therapies in Neuro-Oncology

The Response Assessment of Neuro-Oncology (RANO) Working Group is an international, Multidisciplinary effort to develop new standardized response Clinical trials in Brain tumors. The Surgery Working Group of Neuro oncology identified surgically related End-point evaluation problems that were not addressed in the original MacDonald criteria. This led to the initiation of an International effort in Neuro Oncology to develop Novel Response and Progression Assessment Criteria.

Track 13:   Advancements in Neuro-Oncology

In low-grade Gliomas, stereotactically guided conformal Radiotherapy should lead to a significant reduction of Radiation-associated late toxicity, while it selected groups of high-grade Gliomas the use of adjuvant or Neo-adjuvant Chemotherapy may improve survival. In primitive Neuroectodermal Tumors Prognostic Biological markers have been identified that are undergoing prospective evaluation. Infants the use of post-surgical chemotherapy alone may allow the postponing of Radiotherapy for selected cases. For patients with localized Medulloblastomas a new standard treatment is to emerging that uses reduced-dose Craniospinal Radiotherapy followed by Platinum-based chemotherapy, while in Supratentorial primitive Neuroectodermal tumours future treatment will be aimed at improving local control.

Track 14:  Brain and Spine Neurosurgery

Neurosurgery is a complex surgical method that presupposes treatment, diagnosis, and rehabilitation of disorders affecting any region of the Nervous System. Some of the preponderance common Neuro surgeries are skull base surgery, Image Guided Surgery, Laser Surgery, Spinal Neurosurgery and Neuro surgical treatment.

The Global Neurosurgery market is expected to raise 11.75% over the session of 2014-2019. Neurosurgery session includes Image Guided Surgery, Laser Surgery, Surgical operation for brain fibro adenoma, Spinal Neurosurgery, Skull base surgery, Neuro surgical treatment, Geriatric Neurosurgery, latest innovations and techniques.

Track 15:   Advancements in Brain Tumor

The upcoming implementation of Neurosurgical ablation device that provides controlled therapy for brain lesions those are difficult to reach and treat. This tool, will allow us to introduce the probe into the tumor and destroy it without having to perform a Surgical Operation of Craniotomy.

Recent advances and treatment for brain tumors much safer and more successful. Some of these newer techniques are include.

  • Antiseizure/Antiepileptic Drugs (AEDs)
  • Steroids
  • Surgery: The goal of surgery in the treatment of metastasis is to maximally remove tumor while leaving patients with good function
  • Radiosurgery: A non-invasive technique that delivers numerous narrow, precisely aimed, highly focused beams of ionizing radiation that converge at a specific point.
  • Radiation therapy: X-rays and other forms of radiation can destroy tumor cells or delay tumor   growth.
  • Chemotherapy: The use of drugs to kill rapidly dividing cells. It can be taken orally or intravenously.
  • Targeted therapy: The focus on a specific element of a cell, such as molecules or pathways required for cell growth, in order to use them as a target.

Track 16:   Brain Tumor Diagnosis

The following are the steps involved in Brain Tumor Diagnosis;

  •  A neurological exam: A neurological exam may include, among other things, checking your vision,            hearing, balance, coordination, strength and reflexes. Difficulty in one or more areas may provide clues        about the part of your brain that could be affected by a brain tumor.
  •   Imaging tests: Magnetic Resonance Imaging (MRI) is commonly used to help diagnose brain tumors.           In some cases a dye may be injected through a vein in your arm during your MRI study.

   A number of specialized MRI scan components — including functional MRI, perfusion MRI and Magnetic Resonance Spectroscopy

Other imaging tests may include Computerized Tomography (CT) scan and Positron Emission Tomography (PET).

  • Tests to find cancer in other parts of your body: If it's suspected that your Brain tumor may be a result of Cancer that has spread from another area of your body, your doctor may recommend tests and procedures to determine where the cancer originated. One example might be a CT scan of the chest to look for signs of Lung Cancer.
  • Collecting and testing a sample of abnormal tissue (biopsy): A Biopsy can be performed as part of an operation to remove the Brain tumor, or a Biopsy can be performed using a needle.

A stereotactic needle biopsy may be done for brain tumors in hard to reach areas or very sensitive areas within your brain that might be damaged by a more extensive operation. Your Neurosurgeon drills a small hole into your skull. A thin needle is then inserted through the hole. Tissue is removed using the needle, which is frequently guided by CT or MRI scanning.

The Biopsy sample is then viewed under a microscope to determine if it is cancerous or benign. This information is critical to establish a diagnosis and prognosis and, most importantly, in guiding treatment.

Track 17:  Radiation Oncology

Radiation Oncology encompasses all facet, of research that whack, on the treatment of cancer using radiation. It discloses verdict in molecular and cellular radiation oncology, radiation technology, radiation physics, and clinical oncology.

Track 18:    Medical Treatment of Metastatic Cancer to the Nervous System

A Metastatic Cancer which has spread from the primary site of origin into different area of the body parts. That occurs in about one-fourth of all cancers that spread through the body.Treatment for Metastatic Cancer which aims to slow the growth or spread of the Cancer. Treatment depends on the type of cancer, where it started, size and location of the Metastasis and other factors for proper care.

The primary tumor may be found by examining tumor tissues from the brain. Tests may include; Cerebral Angiography, Mammogram, Chest x-ray, CT scans of the Chest, Abdomen, and Pelvis to find the original tumor site, MRI of the Brain, Lumbar puncture, EEG.

Track 19:   Treatment of cancer related complications

Occurrence of Cancer related complications are seen during Chemotherapy because the dividing blood cells in bone marrow are also prone to damage from medications used in treatment also many of these side effects can be attributed to low blood counts. In rare cases, some Chemotherapy drugs can cause Heart damage or trigger another cancer such as Leukaemia. 

Relevant Conferences: Neuro Oncology ConferencesOncology Conferences | Neuro Oncology Workshop | Neuro Oncology eventsCancer  and Oncology Conference | Oncology events | Oncology meetings | Brain tumor conference | Brain cancer Conference

Neuro Oncology 2020 welcomes attendees, presenters, and exhibitors from all over the world to Tokyo, Japan. We are delighted to invite you all to attend and register for the 6th International Conference on Neuro-Oncology and Brain Tumor which is going to be held during June 22-23, 2020 Brisbane, Australia.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuro Oncology 2020, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Neuro-oncology 2020 organizing committee look forward to meeting you in Brisbane, Australia.

For more details please visit-

Importance and Scope:

6th International Conference on Neuro-Oncology and Brain Tumor is a unique forum to bring together worldwide distinguished academics in the field of neurooncology and brain tumor, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Neuroscience.

Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Neuroscience and its allied areas.

Why Brisbane?

Cancer Australia is the lead tumour control agency to the Australia. The organisation was founded to raise cancer awareness to support those affected by cancer within Australia and its regions. The main ambition of the organisation is to advise the Government on cancer control, develop policies, and to assist those living with cancer.

Cancer Australia collaborates including a wide range of groups, including those affected by cancer, service providers with an interest in cancer control, as well as stakeholders. The agency also focuses on populations who experience poorer health outcomes, with aboriginal Australians living in remote areas within Australia. In August 2014-2018 Cancer Australia, launched the first national Pediatric Cancer in Australia.

Conference Highlights:

  • Neuro-Oncology & BrainTumours
  • Radiation Oncology
  • Pediatric Neuro Oncology
  • Novel Therapies in Neuro-Oncology
  • Advancements in Neuro-Oncology
  • Cancer Pharmacology and Toxicology
  • Brain Mapping & Biomarkers
  • Advancements in Brain Tumor
  • Neurosurgery and Spine Surgery
  • Metastatic Cancer
  • Treatment of Cancer related complications
  • Brain tumor Case Studies
  • Nursing care in Brain tumor
  • Medical Treatment of Metastatic Cancer to the Nervous System
  • Brain Tumor Diagnosis
  • Neuropathology in Cancer
  • Angiogenesis in Neuro Oncology

Why to attend???

Neuro-oncology and Therapeutics is a unique forum to bring together worldwide distinguished academics in the field of neurooncology and cancer, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Brain disorders.

A Unique Opportunity for Advertisers and Sponsors at this International event:

 Major Associations around the Globe

  • Neuropathy Association
  • The brain & behaviour research foundation
  • Alzheimer's Association
  • American Academy of Neurology
  • European Neurological Societies
  • World Federation of Neurology
  • Spanish Society of Neurology
  • Major Neurological Associations in Italy
  • Hilarescere Foundation in Italy
  • Italian MS society in Italy   
  • Southern Clinical Neurological Society
  • ESNR European Society of Neuroradiology
  • Vision sciences society

Major Cleveland Clinics and Hospitals for Neuro-Oncology & Neurosurgery across the globe:

  • Neurological Institute at Cleveland Clinic Abu Dhabi
  • The Gerry & Nancy Pencer Brain Tumor Centre Toronto, Canada
  • Brain Tumour Foundation of Canada
  • Sunnybrook Health Sciences Centre
  • Municipal Nerve Hospital, Japan
  • Naval Hospital Yokosuka, Japan
  • St. Luke's International Hospital, Japan
  • National Hospital for Neurology and Neurosurgery, Queen Square
  • Walton Centre, Liverpool
  • Royal Hospital for Neuro-disability, Putney
  • London Bridge Hospital
  • St George's Hospital, UK
  • King's College Hospital, UK
  • Clinic NeuroVita, Russia
  • Beacon Hospital, Malaysia

List of cancer drugs approved by the FDA for use in brain tumors

  • Gliolan
  • TRXE-009
  • Temozolomide
  • Afinitor (Everolimus)
  • Afinitor Disperz (Everolimus)
  • Avastin (Bevacizumab)
  • Becenum (Carmustine)
  • Bevacizumab
  • BiCNU (Carmustine)
  • Carmubris (Carmustine)
  • Carmustine
  • Carmustine Implant
  • CeeNu (Lomustine)
  • Everolimus
  • Gliadel (Carmustine Implant)
  • Gliadel wafer (Carmustine Implant)
  • Lomustine
  • Methazolastone (Temozolomide)
  • Temodar (Temozolomide)

Target Audience:

Academia 60%

Industry   30%

Others       10%

A major part of research is going on the top Universities on Neuro-Oncology across the globe:

  • Stanford University in California
  • Columbia University Medical Center
  • UC San Diego
  • CERN Medical Research
  • University of Wolver Hampton
  • University of Chicago
  • University Hospital Heidelberg
  • University of Michigan Health System
  • Duke University in Durham, NC
  • Washington University in St. Louis, MO
  • University of California
  • Harvard Medical School
  • UCSF School of Medicine
  • Perelman School of Medicine
  • Yale School of Medicine
  • Maryland School of Medicine
  • Warren Alpert Medical School
  • University of Virginia.
  • University of Rochester Medical Centre

Major Associations and Societies of Neuro-Oncology and Brain Tumor Worldwide:

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date June 22-23, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View